The influence of huntingtin protein size on nuclear localization and cellular toxicity

Journal of Cell Biology

Volumn 141, Issue 5, 1998, Pages 1097-1105

  Hackam, Abigail S ^b   Singaraja, Roshni ^b   Wellington, Cheryl L ^b   Metzler, Martina ^b   McCutcheon, Krista ^b   Zhang, Taiqi ^b   Kalchman, Michael ^b   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUTAMINE; HUNTINGTIN; MUTANT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; KIDNEY CELL; MOLECULAR SIZE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; STEM CELL;

ANIMALS; APOPTOSIS; CELL LINE; CELL NUCLEUS; HUMANS; HUNTINGTON DISEASE; MICE; MOLECULAR WEIGHT; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS;

ANIMALIA;

EID: 0032101287     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.141.5.1097     Document Type: Article

References (30)

1. Andrew, S.E., Y.P. Goldberg, and M.R. Hayden. 1997. Commentary: rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum. Mol. Genet. 6:2005-2010.
2. Becher, M.W., J.A. Kotzuk, A.H. Sharp, S.W. Davies, G.P. Bates, D.L. Price, and C.A. Ross. 1997. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and palidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol. Dis. In press.
3. Carmichael, J., W.G. DeGraff, A.F. Gazdar, J.D. Minna, and J.B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:936-942.
4. Chen, C.F., S. Li, Y. Chen, P.L. Chen, Z.D. Sharp, and W.H. Lee. 1996. The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal receptor. J. Biol. Chem. 271: 32863-32868.
5. Cooper, J.K., G. Schilling, M.F. Peters, W.J. Herring, A.H. Sharp, Z. Kaminsky, J. Masone, F.A. Khan, M. Delanoy, D.R. Borchelt, et al. 1998. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7:783-790.
6. Couldwell, W.T., D.R. Hinton, S. He, T.C. Chen, I. Sebat, M.H. Weiss, and R.E. Law. 1994. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS (Fed. Euro. Biochem. Soc.) Lett. 345:43-46.
7. Davies, S.W., M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini, and G.P. Bates. 1997. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90:537-548.
8. DiFiglia, M., E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N. Aronin. 1997. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1990-1993.
9. Dingwall, C., and R.A. Laskey. 1991. Nuclear targeting sequences - a consensus? Trends Biochem. Sci. 16:478-481.
10. Efthymiadis, A., H. Shao, S. Hubner, and D.A. Jans. 1997. Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence (NLS) in vivo and in vitro. A comparison with the SV40 large T-antigen NLS. J. Biol. Chem. 272:22134-22139.
11. Goldberg, Y.P., M.A. Kalchman, M. Metzler, J. Nasir, J. Zeisler, R. Graham, H.B. Koide, J. O'Kusky, A.H. Sharp, C.A. Ross, et al. 1996. Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum. Mol. Genet. 5:177-185.
12. Goldfarb, D.S., J. Gariepy, G. Schoolnik, and R.D. Kornberg. 1986. Synthetic peptides as nuclear localization signals. Nature. 322:641-644.
13. Gorlich, D., and I.W. Mattaj. 1996. Nucleocytoplasmic transport. Science. 271: 1513-1518.
14. Hodgson, J.G., D.J. Smith, K. McCutcheon, H.B. Koide, K. Nishiyama, M.B. Dinulos, M.E. Stevens, N. Bissada, J. Nasir, K. Kanazawa, et al. 1996. Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum. Mol. Genet. 5:1875-1885.
15. Igarashi, S., R. Koide, T. Shimohata, M. Yamada, Y. Hayashi, H. Takano, H. Date, M. Oyake, T. Sato, A. Sato, et al. 1998. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat. Genet. 18:111-117.
16. Kalchman, M.A., H.B. Koide, K. McCutcheon, R.K. Graham, K. Nichol, K. Nishiyama, F.C. Lynn, P. Kazemi-Esfarjani, C.L. Wellington, M. Metzler, et al. 1997. HIP1, a human homolog of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet. 16:44-53.
17. Martindale, D., A.S. Hackam, A. Wieczorek, L. Ellerby, C.L. Wellington, K. McCutcheon, R. Singaraja, P. Kazemi-Esfarjani, R. Devon, D.E. Bredesen, et al. 1998. Length of the protein and polyglutamine tract influence localization and frequency of intracellular aggregates of huntingtin. Nat. Genet. 18: 150-154.
18. Metzler, M., A. Gertz, M. Sarkar, H. Schachter, J.W. Schrader, and J.D. Marth. 1994. Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO (Eur. Mol. Biol. Organ.) J. 13:2056-2065.
19. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65: 55-63.
20. Nasir, J., S.B. Floresco, J.R. O'Kusky, V.M. Diewert, J.M. Richman, J. Zeisler, A. Borowski, J.D. Marth, A.G. Phillips, and M.R. Hayden. 1995. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 81:811-823.
21. Newmeyer, D.D., J.M. Lucocq, T.R. Burglin, and E.M. De Robertis. 1986. Assembly in vitro of nuclei active in nuclear protein transport: ATP is required for nucleoplasmin accumulation. EMBO (Eur. Mol. Biol. Organ.) J. 5:501-510.
22. Paulson, H.L., M.K. Perez, Y. Trottier, J.Q. Trojanowski, S.H. Subramony, S.S. Das, P. Vig, J.-L. Mandel, K.H. Fischbeck, and R.N. Pittman. 1997. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 19:333-344.
23. Ross, C.A. 1995. When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron. 15:491-496.
24. Sapp, E., C. Schwarz, K. Chase, P.G. Bhide, A.B. Young, J. Penney, J.P. Vonsattel, N. Aronin, and M. DiFiglia. 1997. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42:604-612.
25. Scherzinger, E., R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, R. Hasenbank, G.P. Bates, S.W. Davies, H. Lehrach, and E.E. Wanker. 1997. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 90:549-558.
26. Skinner, V.J., B.T. Koshy, C.J. Cummings, I.A. Klement, K. Helin, A. Servadio, H.Y. Zoghbi, and H.T. Orr. 1997. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 389:971-974.
27. Vistica, D.T., P. Skehan, D. Scudiero, A. Monks, A. Pittman, and M.R. Boyd. 1991. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 51:2515-2520.
28. Wellington, C.L., and M.R. Hayden. 1997. Of molecular interactions, mice and mechanisms: new insights into Huntington's disease. Curr. Opin. Neurol. 10: 291-298.
29. Wellington, C.L., L.M. Ellerby, A.S. Hackam, R.L. Margolis, M.A. Trifiro, R. Singaraja, K. McCutcheon, G.S. Salvesen, S.S. Propp, M. Bromm, et al. 1998. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273:9159-9167.
30. Zasloff, M. 1983. tRNA transport from the nucleus in a eukaryotic cell: carrier-mediated translocation process. Proc. Natl. Acad. Sci. USA. 80:6436-6440.